181 related articles for article (PubMed ID: 12793594)
21. A novel pathway to the manifestations of metabolic syndrome.
Sonnenberg GE; Krakower GR; Kissebah AH
Obes Res; 2004 Feb; 12(2):180-6. PubMed ID: 14981209
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention.
Schernthaner GH; Schernthaner G
Scand J Clin Lab Invest Suppl; 2005; 240():30-40. PubMed ID: 16112958
[TBL] [Abstract][Full Text] [Related]
23. Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization.
Saraf N; Sharma PK; Mondal SC; Garg VK; Singh AK
J Pharm Pharmacol; 2012 Feb; 64(2):161-71. PubMed ID: 22221092
[TBL] [Abstract][Full Text] [Related]
24. Lpin1 in human visceral and subcutaneous adipose tissue: similar levels but different associations with lipogenic and lipolytic genes.
Miranda M; Escoté X; Alcaide MJ; Solano E; Ceperuelo-Mallafré V; Hernández P; Wabitsch M; Vendrell J
Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E308-17. PubMed ID: 20530740
[TBL] [Abstract][Full Text] [Related]
25. Adiponectin, the missing link in insulin resistance and obesity.
Gil-Campos M; Cañete RR; Gil A
Clin Nutr; 2004 Oct; 23(5):963-74. PubMed ID: 15380884
[TBL] [Abstract][Full Text] [Related]
26. Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.
Walker GE; Marzullo P; Verti B; Guzzaloni G; Maestrini S; Zurleni F; Liuzzi A; Di Blasio AM
Obesity (Silver Spring); 2008 Sep; 16(9):1983-91. PubMed ID: 19186324
[TBL] [Abstract][Full Text] [Related]
27. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
[TBL] [Abstract][Full Text] [Related]
28. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
Wisse BE
J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
[TBL] [Abstract][Full Text] [Related]
29. [Obesity, insulin resistance and the implication of thiazolidinediones].
Oguma Y; Kataoka K
Nihon Rinsho; 2000 Feb; 58(2):411-5. PubMed ID: 10707567
[TBL] [Abstract][Full Text] [Related]
30. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome.
Heinonen MV; Laaksonen DE; Karhu T; Karhunen L; Laitinen T; Kainulainen S; Rissanen A; Niskanen L; Herzig KH
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):626-33. PubMed ID: 19278844
[TBL] [Abstract][Full Text] [Related]
31. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
Salmenniemi U; Ruotsalainen E; Pihlajamäki J; Vauhkonen I; Kainulainen S; Punnonen K; Vanninen E; Laakso M
Circulation; 2004 Dec; 110(25):3842-8. PubMed ID: 15596567
[TBL] [Abstract][Full Text] [Related]
32. The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue.
Kovacova Z; Tencerova M; Roussel B; Wedellova Z; Rossmeislova L; Langin D; Polak J; Stich V
Int J Obes (Lond); 2012 Oct; 36(10):1360-5. PubMed ID: 22143618
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological treatment of insulin resistance in obesity.
Camejo G; Ljung B; Oakes N
Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4):275-84. PubMed ID: 11831112
[TBL] [Abstract][Full Text] [Related]
34. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism.
Flachs P; Rossmeisl M; Bryhn M; Kopecky J
Clin Sci (Lond); 2009 Jan; 116(1):1-16. PubMed ID: 19037880
[TBL] [Abstract][Full Text] [Related]
35. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
[TBL] [Abstract][Full Text] [Related]
36. Adiponectin: novelties in metabolism and hormonal regulation.
Duntas LH; Popovic V; Panotopoulos G
Nutr Neurosci; 2004 Aug; 7(4):195-200. PubMed ID: 15682645
[TBL] [Abstract][Full Text] [Related]
37. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
Qi Z; Xue J; Zhang Y; Wang H; Xie M
Planta Med; 2011 Feb; 77(3):231-5. PubMed ID: 20717873
[TBL] [Abstract][Full Text] [Related]
38. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.
Burgert TS; Taksali SE; Dziura J; Goodman TR; Yeckel CW; Papademetris X; Constable RT; Weiss R; Tamborlane WV; Savoye M; Seyal AA; Caprio S
J Clin Endocrinol Metab; 2006 Nov; 91(11):4287-94. PubMed ID: 16912127
[TBL] [Abstract][Full Text] [Related]
39. Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β up-regulation.
Powell LA; Crowe P; Kankara C; McPeake J; McCance DR; Young IS; Trimble ER; McGinty A
Clin Sci (Lond); 2012 Aug; 123(3):135-46. PubMed ID: 22309242
[TBL] [Abstract][Full Text] [Related]
40. Adiponectin--a key adipokine in the metabolic syndrome.
Whitehead JP; Richards AA; Hickman IJ; Macdonald GA; Prins JB
Diabetes Obes Metab; 2006 May; 8(3):264-80. PubMed ID: 16634986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
